Alta Partners Management Company, L.P. Tyra Biosciences, Inc. Transaction History
Alta Partners Management Company, L.P.
- $41.8 Billion
- Q1 2025
A detailed history of Alta Partners Management Company, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Alta Partners Management Company, L.P. holds 4,080,296 shares of TYRA stock, worth $42.6 Million. This represents 90.83% of its overall portfolio holdings.
Number of Shares
4,080,296
Previous 4,080,296
-0.0%
Holding current value
$42.6 Million
Previous $56.7 Billion
33.09%
% of portfolio
90.83%
Previous 89.47%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
123Shares Held
55.1MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$111 Million2.05% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$42.4 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$42.4 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$41.2 Million1.61% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA3.61MShares$37.7 Million96.23% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $439M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...